CompuGroup Medical SE KGaA Management
Management criteria checks 2/4
CompuGroup Medical SE KGaA's CEO is Daniel Gotthardt, appointed in Sep 2024, has a tenure of less than a year. directly owns 6.92% of the company’s shares, worth €77.87M. The average tenure of the management team and the board of directors is 2.1 years and 3.9 years respectively.
Key information
Daniel Gotthardt
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 6.9% |
| Management average tenure | 2.1yrs |
| Board average tenure | 3.9yrs |
Recent management updates
Recent updates
Is It Too Late To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Nov 26
CompuGroup Medical SE & Co. KGaA's (ETR:COP) Popularity With Investors Is Clear
Nov 08Here's What's Concerning About CompuGroup Medical SE KGaA's (ETR:COP) Returns On Capital
Sep 06Here's Why CompuGroup Medical SE KGaA (ETR:COP) Has A Meaningful Debt Burden
Aug 20What You Can Learn From CompuGroup Medical SE & Co. KGaA's (ETR:COP) P/E After Its 34% Share Price Crash
Aug 04CompuGroup Medical SE & Co. KGaA (ETR:COP) Just Reported Earnings, And Analysts Cut Their Target Price
Jul 18Is It Too Late To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Jul 15Investors Still Waiting For A Pull Back In CompuGroup Medical SE & Co. KGaA (ETR:COP)
Jun 11The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence
May 24Earnings Release: Here's Why Analysts Cut Their CompuGroup Medical SE & Co. KGaA (ETR:COP) Price Target To €43.20
May 11CompuGroup Medical SE KGaA (ETR:COP) Will Pay A Larger Dividend Than Last Year At €1.00
Apr 27CompuGroup Medical SE KGaA's (ETR:COP) Upcoming Dividend Will Be Larger Than Last Year's
Apr 12We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Mar 20CompuGroup Medical SE & Co. KGaA (ETR:COP) Shares Could Be 49% Below Their Intrinsic Value Estimate
Feb 08Investors Interested In CompuGroup Medical SE & Co. KGaA's (ETR:COP) Earnings
Jan 25Is It Time To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Jan 12The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence
Dec 28We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Dec 15Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Potentially Undervalued?
Oct 09CompuGroup Medical SE KGaA (ETR:COP) Could Be Struggling To Allocate Capital
Sep 22Do CompuGroup Medical SE KGaA's (ETR:COP) Earnings Warrant Your Attention?
Sep 07Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 33% Discount?
Aug 23Here's Why CompuGroup Medical SE KGaA (ETR:COP) Can Manage Its Debt Responsibly
Jul 13At €46.82, Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Worth Looking At Closely?
Jun 24CompuGroup Medical SE KGaA (ETR:COP) Is Reinvesting At Lower Rates Of Return
May 27CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50
May 11Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 32% Discount?
May 06We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Apr 06What Does CompuGroup Medical SE & Co. KGaA's (ETR:COP) Share Price Indicate?
Mar 07Be Wary Of CompuGroup Medical SE KGaA (ETR:COP) And Its Returns On Capital
Feb 06An Intrinsic Calculation For CompuGroup Medical SE & Co. KGaA (ETR:COP) Suggests It's 28% Undervalued
Jan 21These 4 Measures Indicate That CompuGroup Medical SE KGaA (ETR:COP) Is Using Debt Reasonably Well
Jan 05Is Now An Opportune Moment To Examine CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Dec 06CEO
Daniel Gotthardt (51 yo)
less than a year
Tenure
€60,000
Compensation
Dr. Daniel Gotthardt is MD & CEO of CompuGroup Medical SE & Co. KGaA since September 1, 2024 and had been its Chief Medical Officer since 2023 until September 2024 and was its Senior Vice President from 20...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD of Impatient & Social Care and Member of the Management Board | 6.1yrs | €1.77m | 0.0077% € 87.0k | |
| MD of Ambulatory Information Systems Europe & Member of Management Board | 3.1yrs | €690.00k | 0.0014% € 15.2k | |
| MD of Ambulatory Information Systems DACH & Member of the Management Board | 1.1yrs | €2.40m | 0.00057% € 6.4k | |
| MD & CEO | less than a year | €60.00k | 6.92% € 77.9m | |
| MD, CFO & Member of Management Board | less than a year | no data | no data | |
| Corporate Vice President of Investor Relations | no data | no data | no data | |
| Senior Vice President of Connectivity | 4.8yrs | no data | no data |
2.1yrs
Average Tenure
50.5yo
Average Age
Experienced Management: COP's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of Supervisory Board | 4.5yrs | €100.00k | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Member of Supervisory Board | 4.5yrs | €48.00k | no data | |
| Member of Supervisory Board | 4.5yrs | €40.00k | no data | |
| Member of Supervisory Board | 4.5yrs | €60.00k | 0.0025% € 28.3k | |
| Member of Supervisory Board | 4.5yrs | €40.00k | 0.015% € 174.0k | |
| Employee Representative Member of Supervisory Board | 3.3yrs | €50.00k | no data | |
| Employee Representative Member of Supervisory Board | 3.3yrs | €40.00k | 0.000070% € 788.0 | |
| Employee Representative Member of Supervisory Board | 3.3yrs | €50.00k | no data | |
| Vice Chairman of the Supervisory Board | 3.3yrs | €60.00k | 0.000050% € 562.9 | |
| Employee Representative Member of Supervisory Board | 3.9yrs | €40.00k | no data | |
| Member of Supervisory Board | 1.8yrs | €34.00k | 0.00039% € 4.4k |
3.9yrs
Average Tenure
57yo
Average Age
Experienced Board: COP's board of directors are considered experienced (3.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 09:25 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
CompuGroup Medical SE & Co. KGaA is covered by 19 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gerhard Schwarz | Baader Helvea Equity Research |
| Knut Woller | Baader Helvea Equity Research |
| Gunnar Cohrs | Berenberg |